| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 392.974 | 90 |
| GSM780708 | Untreated after 4 days (C2_1) | 331.003 | 88 |
| GSM780709 | Untreated after 4 days (C3_1) | 292.014 | 87 |
| GSM780719 | Untreated after 4 days (C1_2) | 423.172 | 90 |
| GSM780720 | Untreated after 4 days (C2_2) | 366.955 | 89 |
| GSM780721 | Untreated after 4 days (C3_2) | 353.792 | 89 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 288.449 | 87 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 406.008 | 90 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 337.219 | 88 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 339.06 | 88 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 471.878 | 91 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 384.99 | 90 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 383.643 | 89 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 360.332 | 89 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 434.915 | 91 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 441.345 | 91 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 390.624 | 90 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 390.624 | 90 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 428.927 | 90 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 385.283 | 90 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 353.661 | 89 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 427.691 | 90 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 366.155 | 89 |